基本信息
文件名称:KR019-生命科学试剂-MCE.pdf
文件大小:463.44 KB
总页数:1 页
更新时间:2025-05-24
总字数:约1.75千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

KR019

Cat.No.:HY-173121

分?式:C??H??F?N?O?S

分?量:433.38

作?靶点:HBV

作?通路:Anti-infection

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性KR019是?种强效的?型肝炎病毒(HBV)?壳组装调节剂,在HBV细胞中表现出强效的抗病毒活性。KR019

能够与核?蛋??聚体-?聚体界?处的疏??袋结合,将?壳组装误导??基因组的?壳中,从?抑制病毒

复制。

REFERENCES

[1].AbbasSA,et,al.Developmentofsulfamoylbenzamide-basedcapsidassemblymodulatorsforhepatitisBviruscapsidassembly.EurJ

MedChem.2025Jun5:290:117430.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE

1/1MasterofBioactiveMolecules—您?边的抑制剂?师